PubMed ID:
22417277
Public Release Type:
Journal
Publication Year: 2012
Affiliation: University of Michigan, Ann Arbor, MI, USA. wherman@umich.edu
DOI:
https://doi.org/10.1111/j.1464-5491.2012.03644.x
Authors:
DCCT/EDIC Research Group,
Feldman EL,
Albers JW,
Cleary PA,
Martin CL,
Braffett BH,
Pop-Busui R,
Herman WH
Studies:
Diabetes Control and Complications Trial
The Michigan Neuropathy Screening Instrument (MNSI) is used to assess distal symmetrical peripheral neuropathy in diabetes. It includes two separate assessments: a 15-item self-administered questionnaire and a lower extremity examination that includes inspection and assessment of vibratory sensation and ankle reflexes. The purpose of this study was to evaluate the performance of the MNSI in detecting distal symmetrical peripheral neuropathy in patients with Type 1 diabetes and to develop new scoring algorithms.